PMID- 23554785 OWN - NLM STAT- PubMed-not-MEDLINE DCOM- 20130405 LR - 20211021 IS - 1674-8301 (Print) IS - 1674-8301 (Linking) VI - 26 IP - 6 DP - 2012 Nov TI - Serum IL-10 from systemic lupus erythematosus patients suppresses the differentiation and function of monocyte-derived dendritic cells. PG - 456-66 LID - 10.7555/JBR.26.20120115 [doi] AB - The role played by cytokines, other than interferon (IFN)-alpha, in the differentiation and function of dendritic cells (DCs) in systemic lupus erythematosus (SLE), remains unclear. Serum interleukin-10 (IL-10) levels are generally elevated in SLE patients, which might modulate the differentiation of DCs. In this study, DCs were induced from monocytes either by transendothelial trafficking or by culture with granulocyte-macrophage colony-stimulating factor (GM-CSF) + IL-4 + tumor necrosis factor (TNF)-alpha. Both systems were used to investigate the effects of elevated serum IL-10 level on DC differentiation in SLE patients. The results showed that monocyte-derived DCs induced by either SLE serum or exogenous IL-10 reduced the expression of human leukocyte antigen (HLA)-DR and CD80, decreased IL-12p40 level, and increased IL-10 level, and exhibited an impaired capacity to stimulate allogenic T-cell proliferation. These results indicate that serum IL-10 may be involved in the pathogenesis of SLE by modulating the differentiation and function of DCs. FAU - Sun, Zhida AU - Sun Z AD - Department of Oral Mucosal Diseases, the Affiliated Stomatological Hospital, Nanjing Medical University, Nanjing, Jiangsu 210029, China; FAU - Zhang, Rong AU - Zhang R FAU - Wang, Huijuan AU - Wang H FAU - Jiang, Pengtao AU - Jiang P FAU - Zhang, Jiangquan AU - Zhang J FAU - Zhang, Mingshun AU - Zhang M FAU - Gu, Lei AU - Gu L FAU - Yang, Xiaofan AU - Yang X FAU - Zhang, Miaojia AU - Zhang M FAU - Ji, Xiaohui AU - Ji X LA - eng PT - Journal Article DEP - 20121031 PL - China TA - J Biomed Res JT - Journal of biomedical research JID - 101551157 PMC - PMC3597043 OTO - NOTNLM OT - dendritic cells (DCs) OT - differentiation OT - interleukin-10 (IL-10) OT - lupus erythematosus systemic (SLE) COIS- The authors declared no financial conflict of interests. EDAT- 2013/04/05 06:00 MHDA- 2013/04/05 06:01 PMCR- 2012/11/01 CRDT- 2013/04/05 06:00 PHST- 2011/10/09 00:00 [received] PHST- 2011/12/21 00:00 [revised] PHST- 2012/08/29 00:00 [accepted] PHST- 2013/04/05 06:00 [entrez] PHST- 2013/04/05 06:00 [pubmed] PHST- 2013/04/05 06:01 [medline] PHST- 2012/11/01 00:00 [pmc-release] AID - jbr-26-06-456 [pii] AID - 10.7555/JBR.26.20120115 [doi] PST - ppublish SO - J Biomed Res. 2012 Nov;26(6):456-66. doi: 10.7555/JBR.26.20120115. Epub 2012 Oct 31.